Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion.
about
Sequence of an intestinal cDNA encoding human gastric inhibitory polypeptide precursorThe primary structure of human secretogranin I (chromogranin B): comparison with chromogranin A reveals homologous terminal domains and a large intervening variable regionImmunohistochemical expression of neuroendocrine secretory protein-55 (NESP-55) in pituitary adenomasChromostatin, a chromogranin A-derived bioactive peptide, is present in human pancreatic insulin (beta) cellsThe plasminogen activation system and the regulation of catecholaminergic functionIsolation and primary structure of a novel chromogranin A-derived peptide, WE-14, from a human midgut carcinoid tumourChromogranin A: its clinical value as marker of neuroendocrine tumoursIsolation of human pancreastatin fragment containing the active sequence from a glucagonomaAntibacterial activity of glycosylated and phosphorylated chromogranin A-derived peptide 173-194 from bovine adrenal medullary chromaffin granulesPreptin derived from proinsulin-like growth factor II (proIGF-II) is secreted from pancreatic islet beta-cells and enhances insulin secretionTwo chromogranin a-derived peptides induce calcium entry in human neutrophils by calmodulin-regulated calcium independent phospholipase A2Glucose-dependent insulinotropic peptide: structure of the precursor and tissue-specific expression in ratThe novel chromogranin A-derived serpinin and pyroglutaminated serpinin peptides are positive cardiac β-adrenergic-like inotropesCathepsin L colocalizes with chromogranin a in chromaffin vesicles to generate active peptidesNaturally occurring human genetic variation in the 3'-untranslated region of the secretory protein chromogranin A is associated with autonomic blood pressure regulation and hypertension in a sex-dependent fashion.Proteolytic cleavage of chromogranin A (CgA) by plasmin. Selective liberation of a specific bioactive CgA fragment that regulates catecholamine release.Identification of peptides from brain and pituitary of Cpe(fat)/Cpe(fat) micePhosphorylation and O-glycosylation sites of human chromogranin A (CGA79-439) from urine of patients with carcinoid tumors.Defective secretion of islet hormones in chromogranin-B deficient mice.Secretion from chromaffin cells is controlled by chromogranin A-derived peptides.Isolation and primary structure of tumor-derived peptides related to human pancreastatin and chromogranin ASecretory granules in inositol 1,4,5-trisphosphate-dependent Ca2+ signaling in the cytoplasm of neuroendocrine cells.Catestatin: a multifunctional peptide from chromogranin AHypertension from targeted ablation of chromogranin A can be rescued by the human orthologChromogranin A is a reliable serum diagnostic biomarker for pancreatic neuroendocrine tumors but not for insulinomasA mass spectrometry-based method to screen for α-amidated peptides.The adrenal chromaffin granule: a model for large dense core vesicles of endocrine and nervous tissue.Novel peptides from adrenomedullary chromaffin vesiclesSecretory protein traffic. Chromogranin A contains a dominant targeting signal for the regulated pathwayCell type-specific gene expression in the neuroendocrine system. A neuroendocrine-specific regulatory element in the promoter of chromogranin A, a ubiquitous secretory granule core protein.Pancreastatin and islet hormone release.Chromogranin/secretogranin proteins in murine heart: myocardial production of chromogranin A fragment catestatin (Chga(364-384))Secretogranin III is a sulfated protein undergoing proteolytic processing in the regulated secretory pathway.Cellular distribution of chromogranin A in excitatory, inhibitory, aminergic and peptidergic neurons of the rodent central nervous system.Human catestatin peptides differentially regulate infarct size in the ischemic-reperfused rat heartMass spectrometry-based neuropeptidomics of secretory vesicles from human adrenal medullary pheochromocytoma reveals novel peptide products of prohormone processingNaturally occurring genetic variants in human chromogranin A (CHGA) associated with hypertension as well as hypertensive renal disease.Catecholamine storage vesicles: role of core protein genetic polymorphisms in hypertension.Catestatin and vasostatin concentrations in healthy dogsOverview of exocrine pancreatic pathobiology.
P2860
Q24293668-12748D05-84B9-4097-AB5F-A5104A28497EQ24299391-144561A9-5969-4A05-A8F8-FAD7C4256FA1Q24303529-8F745698-6E68-4CC5-A0AF-6E0915B71D74Q24563267-83737DE8-E862-4C8A-B1B5-F686A95A8421Q26862632-02B421E2-D12E-4446-968F-BC59ADF21260Q28240081-804BB12C-4C1A-4663-A175-E7F6F4AE1743Q28278648-750FC2F2-D5A2-4550-95F9-0BA522C62C94Q28280720-1EEA0128-E048-44EE-89A7-D6D3D3C7115EQ28296283-692EE0F4-1D08-4E80-B969-BD17FF3019FAQ28364649-DE4F0E2D-D261-4A75-B641-C56980D9F864Q28474794-0D9BB2E8-69BC-4F25-BD1E-E37D176933FDQ28573441-875B9081-DBF9-449C-93FA-759537382123Q28579371-672F58E3-C929-4C9B-BE60-1C2DEDA429EAQ28579762-B4FEB24B-ECE8-4611-8AFF-98CFA6C781C8Q30486618-CCEF463C-E881-4DC6-A0D0-09ED92452463Q30666998-88029A01-9488-4280-8172-00E045F81034Q31942417-BAF63A2F-7C58-452E-9501-963DE8B8BA44Q31955600-94F4E175-3FF0-4F69-B0D4-7CB68D8D8BCFQ33529121-458A1C30-4202-4A71-A8D3-837A843AD373Q33558750-3EF79C1A-255F-43B9-8FFB-A742B216A720Q33665442-72B37AB4-5E1B-4921-B114-1C46CE99539EQ33694545-FDF264BF-5E48-45DC-B9AD-3556B2D36FAAQ33838302-D0BE522F-D5EE-4983-AF3E-A50E0C17693EQ33865893-7D8AD506-52E0-452A-9F7A-64746DAEEBFAQ34036884-8702A235-3A1F-4381-B0D5-120237AD056DQ34079931-8B168D3E-E3CF-4F38-B0DB-5444BF982E4EQ34087156-4896A0A0-C814-4471-BEAF-D5F103F1F31DQ34087163-0F7422F2-67DC-4987-AAD3-8F0212351489Q34172415-73B1ADEA-DC92-48E9-ADCC-E4D4B73C37E6Q34234389-1DC5F1EC-D566-4538-AEAC-1E1E3F14B403Q34354879-3B4AF5D7-5FB4-4EE2-A798-4A252D1F88C4Q34376655-C56E9805-0644-4C55-AF17-963AF8B86207Q34384733-1F69A2B9-64C5-4FF0-992B-FB796339EC39Q34384775-F8164353-88AC-4FCF-9B1D-E15F47084FEBQ34388245-489C4CFE-BA35-4411-BFC0-8CC6EF20FCC2Q34397442-0CEBF800-E489-4D24-A410-07B62FEFA857Q34435126-6950487A-AB8B-46C9-A411-CB7212E40AF7Q34467436-937A5C04-1750-40C2-A1E1-320443914608Q34548520-B05F3462-1A77-475C-80FF-06CD09692E36Q35180122-692550A4-5784-4F77-8534-95766C7C3DE6
P2860
Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh-hant
name
Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion.
@en
Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion.
@nl
type
label
Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion.
@en
Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion.
@nl
prefLabel
Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion.
@en
Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion.
@nl
P2093
P356
P1433
P1476
Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion.
@en
P2093
P2888
P304
P356
10.1038/324476A0
P407
P577
1986-12-01T00:00:00Z
P6179
1000911488